A very rare side effect among under-31s of the Moderna coronavirus vaccine meant that Belgium stopped using this vaccine last month for the first two vaccine doses of people in this age group.
Younger people can still receive the vaccine for their booster shot (a half dose rather than a full one) but Pfizer’s vaccine is now recommended for the first two doses for all people below the age of 31, based on the advice of the Superior Health Council.
“The decision for the basic vaccination of 18- to 30-year-olds is based on international knowledge of possible side effects that are very rare. We took this decision as a precaution,” Gudrun Briat, the spokesperson for the Vaccination Task Force, told The Brussels Times.
Preliminary indicated that vaccination with Moderna resulted in an increased risk of in young men following the first or second dose in comparison with the Pfizer vaccine.
Younger people can still receive the vaccine for their booster shot (a half dose rather than a full one) but Pfizer’s vaccine is now recommended for the first two doses for all people below the age of 31, based on the advice of the Superior Health Council.
“The decision for the basic vaccination of 18- to 30-year-olds is based on international knowledge of possible side effects that are very rare. We took this decision as a precaution,” Gudrun Briat, the spokesperson for the Vaccination Task Force, told The Brussels Times.
Preliminary indicated that vaccination with Moderna resulted in an increased risk of in young men following the first or second dose in comparison with the Pfizer vaccine.
Comment